Latest AI and machine learning research in parkinson's disease for healthcare professionals.
Psychiatric symptoms in Parkinson's disease (PD) are highly prevalent and challenging to treat. This study maps oscillatory neural activity to diverse psychiatric symptoms in PD, using resting-state subthalamic nucleus (STN) local field potentials (LFPs) and frontal EEG in 55 PD patients undergoing deep brain stimulation (DBS). We tested whether 1) distinct psychiatric symptoms are associated with...
Precision management of Parkinson's disease (PD) requires frequent levodopa (L-dopa) dose adjustments, yet current monitoring relies on subjective symptom reporting and infrequent blood testing. Here, we present a soft, fingertip-mounted wearable platform for continuous, noninvasive L-dopa monitoring. By combining osmotically harvested passive sweat with soft hydrogels, a potentiometric sensing st...
BACKGROUND: Parkinson's disease (PD) progression is highly heterogeneous, complicating clinical management and prognostication. While machine learning...
BACKGROUND: The genesis of Parkinson's disease (PD), a common central neurodegenerative disorder, involves dysregulation of protein posttranslational ...
Motor complications become increasingly prominent as Parkinson's disease (PD) progresses. Although device-aided therapies (DAT) improve symptoms contr...
OBJECTIVES: Early diagnosis of Parkinson's disease (PD) is complicated. Speech impairment, as an early symptom of PD, offers a noninvasive, scalable b...
Major depressive disorder (MDD) is a risk factor for neurodegeneration, yet its heterogeneity makes identifying at-risk subtype challenging. Notably, ...
ObjectiveTo review the application of crowdsourcing and machine learning contests in Parkinson's disease (PD) research, identify best practices for su...
Early diagnosis of Parkinson's disease (PD) is challenging due to the difficulty in identification of various early motor signs. We aimed to develop a...
Robotic-assisted surgery (RAS) extends minimally invasive surgery by restoring dexterity, tremor filtration, and ergonomic console control compared wi...
Parkinson's disease (PD) poses a major unmet therapeutic challenge, with most drug candidates failing in clinical translation despite promising animal...
BACKGROUND: Parkinson's disease is a rapidly growing neurodegenerative disorder with various motor and non-motor symptoms, affecting millions of peopl...
Parkinson's disease (PD) is a progressive neurodegenerative disorder characterized by the pathological misfolding and aggregation of α-synuclein (α-sy...
Artificial intelligence (AI) is increasingly explored across deep brain stimulation (DBS) for movement disorders, yet whether current systems are appr...
BackgroundDigital speech analysis affords robust markers of Parkinson's disease (PD). However, most studies target late-onset PD (LOPD), neglecting ea...
Lysine β-hydroxybutyrylation (Kbhb) is an emerging post-translational modification regulated by β-hydroxybutyrate (BHB), a key metabolic intermediate ...
Cognitive impairment is an important constraint for PwPD with Parkinson's disease (PwPD). Digital assessments potentially provide more accessible meas...
Organic-inorganic hybrid perovskites combine strong optical absorption, long carrier lifetimes, and unusual defect tolerance, yet these favorable prop...
BACKGROUND: Parkinson's disease (PD) remains challenging to diagnose at early stages owing to subtle and heterogeneous clinical manifestations and the...
This study aimed to develop and evaluate a spatiotemporal deep-neural-network (stDNN) using resting-state fMRI (rs-fMRI) data to identify brain biomar...